IRIS
Gennari, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.108
NA - Nord America 2.031
AS - Asia 776
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
AF - Africa 3
Totale 5.940
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.008
IE - Irlanda 1.037
IT - Italia 835
DE - Germania 403
SE - Svezia 367
UA - Ucraina 294
SG - Singapore 249
CN - Cina 168
HK - Hong Kong 131
VN - Vietnam 116
IN - India 56
GB - Regno Unito 52
FR - Francia 41
IR - Iran 24
CA - Canada 23
FI - Finlandia 20
TR - Turchia 14
BE - Belgio 12
NL - Olanda 10
EU - Europa 8
RU - Federazione Russa 6
CZ - Repubblica Ceca 5
PE - Perù 5
AU - Australia 4
ES - Italia 4
KR - Corea 4
LT - Lituania 4
AT - Austria 3
MK - Macedonia 3
PH - Filippine 3
RO - Romania 3
BR - Brasile 2
CH - Svizzera 2
CO - Colombia 2
HR - Croazia 2
JP - Giappone 2
KG - Kirghizistan 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 5.940
Salva come PNG Salva come JPEG
Città #
Dublin 1.032
Jacksonville 597
Piemonte 373
Dearborn 230
Singapore 177
Hong Kong 130
Lawrence 129
Princeton 129
Wilmington 125
Dong Ket 116
Chandler 96
Beijing 79
Ashburn 51
Bremen 47
Ann Arbor 46
San Mateo 44
Milan 32
Boardman 20
Helsinki 20
Toronto 18
Turin 18
Munich 17
Novara 17
Santa Clara 17
Houston 16
Rome 16
Nanjing 14
Andover 13
Norwalk 13
Strasbourg 13
Brussels 12
Monmouth Junction 12
Fairfield 10
Hefei 10
Kunming 10
Odalengo Grande 9
Zanjan 9
Amsterdam 8
Ardabil 8
Grafing 8
North Ridgeville 8
Naples 7
Paris 7
Redwood City 7
Fuzhou 6
London 6
Nardò 6
Torino 6
Vercelli 6
Woodbridge 6
Brno 5
Guangzhou 5
Kocaeli 5
Leawood 5
Lima 5
New York 5
Pavia 5
Sacramento 5
Shenyang 5
Alessandria 4
Augusta 4
Avezzano 4
Bologna 4
Cambridge 4
Chatteris 4
Dallas 4
Florence 4
Frankfurt am Main 4
Jinan 4
Los Angeles 4
Palermo 4
Saint-Fons 4
Songpa-gu 4
Sydney 4
West Jordan 4
Alba 3
Cassano Magnago 3
Castelnuovo Bormida 3
Catanzaro 3
Faenza 3
Gunzenhausen 3
Hebei 3
Minneapolis 3
Pioltello 3
Seattle 3
Stradella 3
Verona 3
Ankara 2
Apice 2
Appiano Gentile 2
Bagnoli del Trigno 2
Berlin 2
Bishkek 2
Boadilla del Monte 2
Bucharest 2
Bulandshahr 2
Busalla 2
Caloocan City 2
Francavilla Fontana 2
Giugliano In Campania 2
Totale 3.977
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 145
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 121
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 104
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 95
Insulin-like Growth Factor-1 Receptor (IGF-1R) expression on Circulating Tumor Cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial 91
Bone health, vitamin D status and oral hygiene screening in breast cancer women before starting osteoporosis treatment: a cross-sectional study 72
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights 71
A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial 64
Curative Lung Metastasectomy Without Concomitant Androgen Deprivation Therapy in Oligometastatic Castration-resistant Prostate Cancer: A Case Report and Review of the Literature 64
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 63
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) 62
Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer 62
Anthracycline-free therapy for HER2-amplified breast cancer 60
ERA-Net TRANSCAN JTC 2011: Critical aspects of the startup procedures of an International Academic Clinical trial (ET-FES), funded by the European Community (EC) and coordinated by an Italian Institution 60
Adjuvant chemotherapy in breast cancer. International perspective 59
Breast Cancer Survivorship, Quality of Life and Late Toxicities 59
Anthracyclines in the management of metastatic breast cancer: state of the art 58
Metastatic mediastinal germ-cell tumor and concurrent COVID-19: when chemotherapy is not deferrable. 58
Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer 57
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial 57
Axillary web syndrome in women after breast cancer surgery referred to an Oncological Rehabilitation Unit: which are the main risk factors? A retrospective case-control study 57
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey 56
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 56
The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it. 55
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy 55
Implications of metabolism-driven myeloid dysfunctions in cancer therapy 55
Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study 55
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT 54
Oncolytic virotherapy: new weapon for breast cancer treatment 54
Aging and endothelial function in normotensive subjects and patients with essential hypertension 53
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial 53
Identification of a prognostic signature based on the expression of genes related to the insulin pathway in early breast cancer 53
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support 52
Apalutamide, darolutamide and enzalutamide for nonmetastatic castration-resistant prostate cancer (nmCRPC) 52
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapy 51
[Management of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma] 51
Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression. 51
Anthracyclines-paclitaxel combinations in the treatment of breast cancer 50
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 50
Early Assessment by PET with FDG of Response to First-Line Chemotherapy of Metastatic Breast Cancer 49
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 49
An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab 48
Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer. 48
Dual block with lapatinib and trastuzumab versus single agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: a meta-analysis of randomized trials 47
Precision Medicine in Systemic Mastocytosis 47
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer 46
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer 46
Bevacizumab and breast cancer: A meta-analysis of first-line phase III studies and a critical reappraisal of available evidence 46
Age influence on some aspects of cardiovascular adaptation to hypertension 46
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: The OnCovid Inflammatory Score 46
SARS-CoV-2 re-infection in a cancer patient with a defective neutralizing humoral response 46
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 46
Why are guidelines not followed in clinical practice? 45
Cardiotoxicity of other Anthracycline Analogues 45
Three-dimensional laser scanning as a reliable and reproducible diagnostic tool in breast cancer related lymphedema rehabilitation: a proof-of-principle study 45
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 45
Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer 44
Impact of Body Mass Index (BMI) on the prognosis of high risk early breast cancer (EBC) patients treated with adjuvant chemotherapy 44
Gestione di nausea e vomito nel paziente oncologico. Utilizzo di cerotti transdermici contenenti granisetron in paziente affetto da neoplasia del distretto cervico-cefalico 44
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients 43
Extending the duration of first-line chemotherapy in metastatic breast cancer: A perspective review 43
A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer 42
Identification and validation of a new set of five genes for prediction of risk in early breast cancer 42
Short- and long-term reproducibility of techniques employed to assess sympathetic tone in humans: a preliminary report 42
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). 42
New combinations with epirubicin in advanced breast cancer 41
The quality of life issue in metastatic breast cancer 41
Survival of metastatic breast carcinoma patients over a 20-year period - A retrospective analysis based on individual patient data from six consecutive studies 41
Cancer and fertility preservation: international recommendations from an expert meeting 41
Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies 41
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review 41
Cardiotossicità da antracicline 41
Duration of Chemotherapy for Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 40
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors 40
Paclitaxel plus epirubicin in advanced breast cancer 40
Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer 40
New Understanding of the Role of Anthracyclines in Early-Stage Breast Cancer: Patient Selection Considerations 39
Insulin breast cancer connection: confirmatory data set the stage for better care. 39
Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel 39
Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial 39
Oral chemotherapy in advanced breast cancer: expert perspectives on its role in clinical practice 39
Breast Cancer Diet "BCD": A Review of Healthy Dietary Patterns to Prevent Breast Cancer Recurrence and Reduce Mortality 39
Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer 38
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis 38
Case histories: breast cancer 37
Epirubicin/taxane combinations in breast cancer: Experience from several Italian trials 37
A Simon's two-stage design trial evaluating the potential role of a kind of honey in preventing chemotherapy-hematopoietic toxicities 37
Whither the PET Scan? The Role of PET Imaging in the Staging and Treatment of Breast Cancer 37
Exemestane for Breast Cancer Prevention: A Critical Shift? 37
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer 37
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study 36
Microinjections of alpha 1- and alpha 2-noradrenergic substances in the cerebellar vermis of decerebrate cats affect the gain of the vestibulospinal reflexes 36
Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer 35
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study 35
Pemetrexed: A promising new treatment for breast cancer 35
Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT 35
The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancer 34
Chemotherapy of non-small-cell lung cancer: Role of erythropoietin in the management of anemia 34
Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients 34
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients 34
Totale 4.998
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.463
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020801 0 0 0 0 0 156 199 56 117 167 104 2
2020/2021946 117 3 108 7 122 34 136 16 130 19 122 132
2021/2022892 65 23 84 107 29 33 60 32 92 60 135 172
2022/20231.814 162 69 132 18 69 138 54 75 992 21 45 39
2023/2024756 90 29 53 26 128 17 126 17 19 13 52 186
2024/2025348 28 26 140 31 53 70 0 0 0 0 0 0
Totale 6.289